Home›Companies›Healthcare›Neuro-Kinesis

Neuro-Kinesis Corp

Develops sensor-equipped surgical tools for physicians and surgeons.

Updated Nov 10, 2026·Latest SEC filing Apr 24, 2026·Suggest an edit

About Neuro-Kinesis

Neuro-Kinesis is a private company based in Inglewood, California. It has reported $551,000 raised in four offerings on Form D since June 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 13, 2026Apr 24, 2026$51,000of $2.0M target5$10,200EquityRule 506(b)Form D ↗
Jun 30, 2021Jul 16, 2021$400,000fully sold1$400KEquity, OptionsRule 506(b)Form D ↗
Jun 1, 2020Jun 11, 2020$50,000of $5.0M target3$16,667EquityRule 506(b)Form D ↗
Jun 5, 2020Jun 11, 2020$50,000of $1.0M target1$50,000Equity, OptionsRule 506(b)Form D ↗
Total, four offerings$551,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Neuro-Kinesis's Form D filed Apr 24, 2026.

Eli Gang
Eli Gang
Director and Chief Medical Officer
Also a director at Cognos Therapeutics.
Josh Shachar
Josh Shachar
Executive officer and director
Also a director at Cognos Therapeutics.
CB
Christopher Bissell
Chief Financial Officer

Earlier filings also listed Frank Adell (director, president and ceo, last listed Jul 2021).

Sources

  1. SECNeuro-Kinesis Corp filing history
  2. CompanyTerms of Use
  3. CompanyAbout Neuro-Kinesis
  4. CompanyTeam
  5. CompanyAnimal study announcement
  6. CompanyTechnology sale negotiations